Nu Skin Enterprises (NYSE:NUS) Posts Earnings Results, Beats Estimates By $0.04 EPS

Nu Skin Enterprises (NYSE:NUSGet Rating) issued its quarterly earnings results on Wednesday. The company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.72 by $0.04, MarketWatch Earnings reports. The business had revenue of $604.90 million for the quarter, compared to the consensus estimate of $579.70 million. Nu Skin Enterprises had a return on equity of 23.39% and a net margin of 5.46%. The business’s quarterly revenue was down 10.7% on a year-over-year basis. During the same period in the prior year, the firm posted $0.91 earnings per share. Nu Skin Enterprises updated its Q2 guidance to $0.75-0.85 EPS and its FY22 guidance to $3.60-3.90 EPS.

Shares of NYSE NUS traded down $1.60 during midday trading on Thursday, reaching $43.12. 28,227 shares of the stock were exchanged, compared to its average volume of 782,866. The company has a 50 day simple moving average of $47.04 and a 200 day simple moving average of $47.61. The stock has a market capitalization of $2.15 billion, a P/E ratio of 15.69 and a beta of 1.24. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.89 and a current ratio of 1.65. Nu Skin Enterprises has a twelve month low of $39.40 and a twelve month high of $62.70.

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 9th. Stockholders of record on Monday, February 28th were issued a dividend of $0.385 per share. The ex-dividend date of this dividend was Friday, February 25th. This represents a $1.54 dividend on an annualized basis and a dividend yield of 3.57%. This is an increase from Nu Skin Enterprises’s previous quarterly dividend of $0.38. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 54.04%.

In related news, Director Andrew D. Lipman sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 22nd. The shares were sold at an average price of $53.27, for a total transaction of $53,270.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Ryan S. Napierski sold 25,000 shares of the stock in a transaction that occurred on Friday, February 25th. The stock was sold at an average price of $47.40, for a total transaction of $1,185,000.00. The disclosure for this sale can be found here. Insiders have sold a total of 28,000 shares of company stock valued at $1,333,390 in the last 90 days. Insiders own 2.80% of the company’s stock.

Several large investors have recently bought and sold shares of the stock. Morgan Stanley boosted its position in Nu Skin Enterprises by 1.9% in the 2nd quarter. Morgan Stanley now owns 360,382 shares of the company’s stock valued at $20,415,000 after buying an additional 6,652 shares during the period. UBS Group AG boosted its position in Nu Skin Enterprises by 13.3% in the 3rd quarter. UBS Group AG now owns 42,922 shares of the company’s stock valued at $1,737,000 after buying an additional 5,040 shares during the period. Janus Henderson Group PLC purchased a new position in Nu Skin Enterprises in the 3rd quarter valued at approximately $208,000. Schonfeld Strategic Advisors LLC purchased a new position in Nu Skin Enterprises in the 4th quarter valued at approximately $455,000. Finally, Allstate Corp boosted its position in Nu Skin Enterprises by 12.4% in the 4th quarter. Allstate Corp now owns 15,684 shares of the company’s stock valued at $796,000 after buying an additional 1,733 shares during the period. 93.79% of the stock is owned by hedge funds and other institutional investors.

Several research firms recently issued reports on NUS. Zacks Investment Research raised Nu Skin Enterprises from a “hold” rating to a “strong-buy” rating and set a $57.00 target price on the stock in a research report on Tuesday, March 29th. StockNews.com initiated coverage on Nu Skin Enterprises in a research report on Thursday, March 31st. They issued a “hold” rating on the stock. Jefferies Financial Group upped their price target on shares of Nu Skin Enterprises from $61.00 to $75.00 in a report on Thursday, February 17th. TheStreet downgraded shares of Nu Skin Enterprises from a “b” rating to a “c+” rating in a report on Friday, February 18th. Finally, DA Davidson increased their price objective on shares of Nu Skin Enterprises from $47.00 to $50.00 and gave the company a “neutral” rating in a report on Thursday, February 17th. Four equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $61.17.

Nu Skin Enterprises Company Profile (Get Rating)

Nu Skin Enterprises, Inc develops and distributes beauty and wellness products worldwide. It provides skin care systems, including ageLOC Spa systems, ageLOC Transformation anti-aging skin care systems, and ageLOC LumiSpa skin treatment and cleansing devices; and ageLOC Boost, as well as a range of other cosmetic and personal care products.

Further Reading

Earnings History for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.